The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...

Delgocitinib cream is more effective and has a better safety profile than oral alitretinoin for the treatment of severe chronic hand eczema.

Topical roflumilast 0.3% cream has been approved by the FDA to treat plaque psoriasis in patients 12 years and older since ...

Crepey skin is the result of both natural aging and external factors. Over time, our skin loses collagen and elastin, becomes ...

The pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories at three dosage strengths and oral syrup were studied. The study had an open-label, randomized ...

The FDA approved a supplemental new drug application for roflumilast topical foam 0.3% for the treatment of plaque psoriasis ...

The approval was supported by data from 2 randomized, double-blind, vehicle-controlled trials that included 736 patients aged 12 years and older with mild to severe plaque psoriasis of the scalp and ...

The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and ...

As more brands focus on efficacy and safety in skin of color, the product benefits are multiplying. We explore this long-overdue development.

After trying it myself, I can attest that the Biofreeze Pain Relief Gel beats any ice pack or even rest after a strenuous ...

It is the first US approval for a topical gene therapy, according to the regulator, which has said Vyjuvek (beremagene geperpavec) can be used to treat patients aged six months of over who have ...

Take stock of your moisturizers — you likely have a facial cream, body lotion or even an eye cream and hand cream, but do you have one specifically for your feet? If not, you probably ...